BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boimel PJ, Berman AT, Li J, Apisarnthanarax S, Both S, Lelionis K, Larson GL, Teitelbaum U, Lukens JN, Ben-Josef E, Metz JM, Plastaras JP. Proton beam reirradiation for locally recurrent pancreatic adenocarcinoma. J Gastrointest Oncol 2017;8:665-74. [PMID: 28890817 DOI: 10.21037/jgo.2017.03.04] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Hanada S, Tsuruta T, Haraguchi K, Okamoto M, Sugiyama H, Koido S. Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines. Hum Vaccin Immunother 2019;15:397-406. [PMID: 30230959 DOI: 10.1080/21645515.2018.1524238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Bhandare MS, Mondal A, Chaudhari V, Bal M, Yadav S, Ramaswamy A, Ostwal V, Shetty N, Shrikhande SV. Factors influencing local and distant recurrence following resection of periampullary cancer. Br J Surg 2021;108:427-34. [PMID: 33723577 DOI: 10.1093/bjs/znaa143] [Reference Citation Analysis]
3 Okamoto M, Shiba S, Okazaki S, Miyasaka Y, Shibuya K, Kiyohara H, Ohno T. Feasibility and Safety of Repeated Carbon Ion Radiotherapy for Locally Advanced Unresectable Pancreatic Cancer. Cancers (Basel) 2021;13:665. [PMID: 33562274 DOI: 10.3390/cancers13040665] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Dell'Oro M, Short M, Wilson P, Bezak E. Clinical Limitations of Photon, Proton and Carbon Ion Therapy for Pancreatic Cancer. Cancers (Basel) 2020;12:E163. [PMID: 31936565 DOI: 10.3390/cancers12010163] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Doyen J, Aloi D, Groulier A, Vidal M, Lesueur P, Calugaru V, Bondiau PY. Role of proton therapy in reirradiation and in the treatment of sarcomas. Cancer Radiother 2021:S1278-3218(21)00123-2. [PMID: 34284969 DOI: 10.1016/j.canrad.2021.06.024] [Reference Citation Analysis]
6 Moningi S, Ludmir EB, Polamraju P, Williamson T, Melkun MM, Herman JD, Krishnan S, Koay EJ, Koong AC, Minsky BD, Smith GL, Taniguchi C, Das P, Holliday EB. Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies. Clin Transl Radiat Oncol 2019;19:59-65. [PMID: 31517071 DOI: 10.1016/j.ctro.2019.08.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
7 Fattahi S, Ahmed SK, Park SS, Petersen IA, Shumway DA, Stish BJ, Yan ES, Remmes NB, Mutter RW, Corbin KS. Reirradiation for Locoregional Recurrent Breast Cancer. Adv Radiat Oncol 2021;6:100640. [PMID: 33506143 DOI: 10.1016/j.adro.2020.100640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Simone CB 2nd, Plastaras JP, Jabbour SK, Lee A, Lee NY, Choi JI, Frank SJ, Chang JY, Bradley J. Proton Reirradiation: Expert Recommendations for Reducing Toxicities and Offering New Chances of Cure in Patients With Challenging Recurrence Malignancies. Semin Radiat Oncol 2020;30:253-61. [PMID: 32503791 DOI: 10.1016/j.semradonc.2020.02.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
9 Shimomura O, Oda T, Hashimoto S, Doi M, Hiroshima Y, Numajiri H, Takahashi K, Furuya K, Miyazaki Y, Owada Y, Ogawa K, Ohara Y, Hisakura K, Akashi Y, Enomoto T, Sakurai H. Survival impact on triple-modal strategy comprising hyperthermia, external radiation, and chemotherapy for unresectable locally advanced (UR-LA) pancreatic ductal adenocarcinoma. Surg Oncol 2021;37:101542. [PMID: 33740629 DOI: 10.1016/j.suronc.2021.101542] [Reference Citation Analysis]
10 Caravatta L, Fiorica F, Rosa C, Boldrini L, Alitto AR, Nardangeli A, Dionisi F, Bianco L, Munoz F, Lupattelli M, Mantello G, Genovesi D, Massaccesi M; Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Role of upper abdominal reirradiation for gastrointestinal malignancies: a systematic review of cumulative dose, toxicity, and outcomes on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Strahlenther Onkol 2020;196:1-14. [DOI: 10.1007/s00066-019-01519-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Chao HH, Berman AT. Proton therapy for thoracic reirradiation of non-small cell lung cancer. Transl Lung Cancer Res 2018;7:153-9. [PMID: 29876314 DOI: 10.21037/tlcr.2018.03.22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Verma V, Rwigema JM, Malyapa RS, Regine WF, Simone CB. Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation. Radiotherapy and Oncology 2017;125:21-30. [DOI: 10.1016/j.radonc.2017.08.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 8.5] [Reference Citation Analysis]
13 Thorpe CS, Niska JR, Girardo ME, Kosiorek HE, McGee LA, Hartsell WF, Larson GL, Tsai HK, Rossi CJ, Rosen LR, Vargas CE. Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis. Breast J 2019;25:1160-70. [PMID: 31338974 DOI: 10.1111/tbj.13423] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
14 Shirai K, Ohno T, Saitoh JI, Okamoto M, Katoh H, Murata K, Kawamura H, Musha A, Abe T, Mizukami T, Akahane K, Nakano T. Prospective Study of Isolated Recurrent Tumor Re-irradiation With Carbon-Ion Beams. Front Oncol 2019;9:181. [PMID: 30972294 DOI: 10.3389/fonc.2019.00181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]